share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 17 04:21
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at an aggregate market value of $191,658.73, were originally acquired on 04/20/2021 through a Pre IPO Option Exercise from the issuer. The acquisition was made with cash payment on the same date. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold, amounting to gross proceeds of $1,562,683.24. The notice of the planned sale was filed on the same date as the intended sale, with the plan for this transaction having been adopted on 03/01/2024.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at an aggregate market value of $191,658.73, were originally acquired on 04/20/2021 through a Pre IPO Option Exercise from the issuer. The acquisition was made with cash payment on the same date. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold, amounting to gross proceeds of $1,562,683.24. The notice of the planned sale was filed on the same date as the intended sale, with the plan for this transaction having been adopted on 03/01/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.